These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9091697)

  • 1. New approaches to the treatment of congenital adrenal hyperplasia.
    Merke DP; Cutler GB
    JAMA; 1997 Apr; 277(13):1073-6. PubMed ID: 9091697
    [No Abstract]   [Full Text] [Related]  

  • 2. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia.
    Charmandari E; Calis KA; Keil MF; Mohassel MR; Remaley A; Merke DP
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3197-200. PubMed ID: 12107224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia.
    Merke DP; Keil MF; Jones JV; Fields J; Hill S; Cutler GB
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1114-20. PubMed ID: 10720048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia.
    Laue L; Merke DP; Jones JV; Barnes KM; Hill S; Cutler GB
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3535-9. PubMed ID: 8855797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with flutamide decreases cortisol clearance: implications for therapy in congenital adrenal hyperplasia.
    Charmandari E; Johnston A; Honour JW; Brook CG; Hindmarsh PC
    J Pediatr Endocrinol Metab; 2002 Apr; 15(4):435-9. PubMed ID: 12008691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Somatic development in a group of 59 children with congenital adrenal hyperplasia in relation to therapy].
    Lisá L
    Cesk Pediatr; 1989 Dec; 44(12):712-3. PubMed ID: 2636554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of patients with congenital adrenal hyperplasia due to 21-hydroxylase in infancy, glucocorticoid requirement and the role of mineralocorticoid therapy.
    Sellick J; Aldridge S; Thomas M; Cheetham T
    J Pediatr Endocrinol Metab; 2018 Sep; 31(9):1019-1022. PubMed ID: 30173205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unresolved problems in the treatment of congenital adrenal hyperplasia.
    Tanae A; Hibi I
    Acta Paediatr Jpn; 1988; 30 Suppl():93-8. PubMed ID: 3146884
    [No Abstract]   [Full Text] [Related]  

  • 9. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
    Bonfig W; Schmidt H; Schwarz HP
    Horm Res Paediatr; 2011; 75(1):32-7. PubMed ID: 20714115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial.
    Moghetti P; Tosi F; Tosti A; Negri C; Misciali C; Perrone F; Caputo M; Muggeo M; Castello R
    J Clin Endocrinol Metab; 2000 Jan; 85(1):89-94. PubMed ID: 10634370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring treatment in congenital adrenal hyperplasia.
    Appan S; Hindmarsh PC; Brook CG
    Arch Dis Child; 1989 Sep; 64(9):1235-9. PubMed ID: 2640553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth and skeletal maturation in congenital adrenal hyperplasia. Review of 20 cases.
    Bailey CC; Komrower GM
    Arch Dis Child; 1974 Jan; 49(1):4-7. PubMed ID: 4361889
    [No Abstract]   [Full Text] [Related]  

  • 14. Modern medical therapy of congenital adrenal hyperplasia. A decade of experience.
    Winter JS; Couch RM
    Ann N Y Acad Sci; 1985; 458():165-73. PubMed ID: 3879120
    [No Abstract]   [Full Text] [Related]  

  • 15. [Congenital adrenal hyperplasia apropos of 7 cases at the University Hospital Center of Dakar].
    Fall M; Sarr M; Sy HS; Ba M; Ould Cheikh A; Diack Mbaye A; Diouf S; Diagne I
    Dakar Med; 1989; 34(1-4):58-63. PubMed ID: 2491387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of hyperandrogenism in women with cyproterone acetate].
    Julesz J; Faredin I; Tóth I; László F
    Orv Hetil; 1981 May; 122(20):1177-80. PubMed ID: 6455637
    [No Abstract]   [Full Text] [Related]  

  • 17. Hirsutes. II: Treatment.
    Young R; Sinclair R
    Australas J Dermatol; 1998 Aug; 39(3):151-7. PubMed ID: 9737040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating antiandrogenic activity in children with congenital adrenal hyperplasia during peroral flutamide treatment.
    Hero M; Jänne OA; Näntö-Salonen K; Dunkel L; Raivio T
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5141-5. PubMed ID: 15985486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia.
    Spritzer P; Billaud L; Thalabard JC; Birman P; Mowszowicz I; Raux-Demay MC; Clair F; Kuttenn F; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1990 Mar; 70(3):642-6. PubMed ID: 2137832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of aromatase inhibitors in precocious puberty.
    Feuillan P; Merke D; Leschek EW; Cutler GB
    Endocr Relat Cancer; 1999 Jun; 6(2):303-6. PubMed ID: 10731123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.